0
Your cart

Your cart is empty

Books > Medicine > Nursing & ancillary services > Biomedical engineering

Buy Now

RNA Delivery Function for Anticancer Therapeutics (Hardcover) Loot Price: R5,553
Discovery Miles 55 530
RNA Delivery Function for Anticancer Therapeutics (Hardcover): Loutfy H. Madkour

RNA Delivery Function for Anticancer Therapeutics (Hardcover)

Loutfy H. Madkour

Series: Nanotechnology for Drugs, Vaccines and Smart Delivery Systems

 (sign in to rate)
Loot Price R5,553 Discovery Miles 55 530 | Repayment Terms: R520 pm x 12*

Bookmark and Share

Expected to ship within 12 - 17 working days

This book presents an overview of the current status of translating the RNAi cancer therapeutics in the clinic, a brief description of the biological barriers in drug delivery, and the roles of imaging in aspects of administration route, systemic circulation, and cellular barriers for the clinical translation of RNAi cancer therapeutics, and with partial content for discussing the safety concerns. It then focuses on imaging-guided delivery of RNAi therapeutics in preclinical development, including the basic principles of different imaging modalities, and their advantages and limitations for biological imaging. With growing number of RNAi therapeutics entering the clinic, various imaging methods will play an important role in facilitating the translation of RNAi cancer therapeutics from bench to bedside. RNAi technique has become a powerful tool for basic research to selectively knock down gene expression in vitro and in vivo. Our scientific and industrial communities have started to develop RNAi therapeutics as the next class of drugs for treating a variety of genetic disorders, such as cancer and other diseases that are particularly hard to address with current treatment strategies. Key Features Provides insight into the current advances and hurdles of RNAi therapeutics. Accelerates RNAi, miRNAs, and siRNA drug development for cancer therapy from bench to bedside. Addresses various modifications and novel delivery strategies for miRNAs, piRNAs and siRNA delivery in anticancer therapeutics. Explores the need for the interaction of hematologists,cell biologists, immunologists, and material scientists in the development of novel cancer therapies. Describes the current status of clinical trials related to miRNA and siRNA-based cancer therapy Presents remaining issues that need to be overcome to establish successful therapies.

General

Imprint: Taylor & Francis
Country of origin: United Kingdom
Series: Nanotechnology for Drugs, Vaccines and Smart Delivery Systems
Release date: 2022
First published: 2022
Authors: Loutfy H. Madkour
Dimensions: 280 x 210mm (L x W)
Format: Hardcover
Pages: 404
ISBN-13: 978-1-03-213516-8
Categories: Books > Medicine > General issues > General
Books > Science & Mathematics > Chemistry > General
Books > Professional & Technical > Technology: general issues > Nanotechnology
Books > Professional & Technical > Environmental engineering & technology > General
Books > Medicine > Other branches of medicine > Pharmacology > General
Books > Medicine > Nursing & ancillary services > Biomedical engineering > General
Books > Science & Mathematics > Biology, life sciences > Life sciences: general issues > General
Books > Professional & Technical > Industrial chemistry & manufacturing technologies > Industrial chemistry > Pharmaceutical technology
Books > Professional & Technical > Mechanical engineering & materials > Materials science > General
LSN: 1-03-213516-6
Barcode: 9781032135168

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners